Skip to main content
Close

Gastrointestinal

Protocols

Resectable Colorectal (Adjuvant)

GIAJCAP

Adjuvant Therapy of Colon Cancer Using Capecitabine    


GIAJCAPOX

Adjuvant Combination Chemotherapy for Stage III and Stage IIB Colon Cancer Using Oxaliplatin and Capecitabine     


GIAJFFOX

Adjuvant Combination Chemotherapy for Stage III and Stage IIB Colon Cancer Using Oxaliplatin, Fluorouracil and Leucovorin


GIAJFL

Adjuvant Therapy of Colon Cancer Using Fluorouracil Injection and Infusion and Leucovorin Infusion    


GIRAJCOX

Adjuvant Combination Chemotherapy for Stage III Rectal Cancer Using Oxaliplatin and Capecitabine      


GIRAJFFOX

Adjuvant Combination Chemotherapy for Stage III Rectal Cancer Using Oxaliplatin, Fluorouracil and Leucovorin


GIRCAP

Adjuvant Therapy for Stage II and III Rectal Cancer Previously Treated with Preoperative Radiation Therapy using Capecitabine         


GIRCRT

Combined Modality Adjuvant Therapy for High Risk Rectal Carcinoma Using Capecitabine and Radiation Therapy     


GIRINFRT

Combined Modality Adjuvant Therapy for High Risk Rectal Carcinoma Using Capecitabine, Infusional Fluorouracil and Radiation Therapy      


Unresectable Colorectal (Advanced)

GIAVCAP

Palliative Therapy of Advanced Colorectal Cancer using Capecitabine   


GIAVCETIR

Third Line Treatment of Metastatic Colorectal Cancer Using Cetuximab in Combination with Irinotecan   


GIAVFL

Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Fluorouracil Injection and Infusion and Leucovorin Infusion


GIAVPANI

Palliative Third Line Treatment of Metastatic Colorectal Cancer Using Panitumumab     


GICAPIRI

Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Irinotecan and Capecitabine in Patients Unsuitable for GIFOLFIRI   


GICAPOX

Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin and Capecitabine         


GICIRB

Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Irinotecan, Bevacizumab and Capecitabine  


GICOXB

Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin, Bevacizumab and Capecitabine 


GIFFIRB

Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Irinotecan, Fluorouracil, Leucovorin and Bevacizumab          


GIFFOXB

Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin, Fluorouracil, Leucovorin and Bevacizumab          


GIFOLFIRI

Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Irinotecan, Fluorouracil and Leucovorin     


GIFOLFOX

Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin, Fluorouracil and Leucovorin    


GIFUFA

Palliative Therapy for Advanced Colorectal Cancer Using Leucovorin and Fluorouracil      


GIIR

First- or Second-Line Palliative Chemotherapy for Metastatic Colorectal Cancer Using Irinotecan


GIIRINALT

Second-line treatment for Fluorouracil refractory metastatic colorectal cancer using weekly scheduled irinotecan  


GIRALT

Palliative Therapy for Unresectable or Metastatic Colorectal Cancer Using Raltitrexed        

Esophagus, Stomach

GIAVDOC

Palliative Treatment of Metastatic Esophagogastric Adenocarcinoma with DOCEtaxel    


GIEFUPRT

Combined Modality Therapy for Locally Advanced esophageal Cancer Using Fluorouracil and CISplatin      


GIENACTRT

Neoadjuvant Treatment of Esophageal and Gastroesophageal Carcinomas Using CARBOplatin, PACLitaxel and Radiation Therapy


GIFUC

Palliative Chemotherapy for Upper Gastrointestinal Tract Cancer (Gastric, Esophageal, Gall Bladder Carcinoma and Cholangiocarcinoma) and Metastatic Anal Cancer Using Infusional Fluorouracil and CISplatin    


GIGAIRT
  • Combined Modality Adjuvant Therapy for Completely Resected Gastric Adenocarcinoma Using Fluorouracil and Folinic Acid (Leucovorin) and Radiation Therapy  

  • GIGAJCC

    Adjuvant Chemotherapy of Gastric Cancer Patients with D2 Resection (Node Negative) or Ineligible for Adjuvant Chemoradiation, Using CISplatin and Capecitabine     


    GIGAJCPRT

    Adjuvant Chemotherapy of Gastric Cancer Patients with Completely Resected Gastric Cancer Using CISplatin and Capecitabine and Radiation Therapy         


    GIGAVCC

    Palliative Therapy for Metastatic or Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Using CISplatin and Capecitabine   


    GIGAVCCT

    Palliative Treatment of Metastatic or Inoperable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma using CISplatin, Capecitabine and Trastuzumab          


    GIGAVCFT

    Palliative Treatment of Metastatic or Inoperable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma using CISplatin, Infusional Fluorouracil and Trastuzumab       


    GIGAVECC

    Palliative Therapy for Metastatic or Locally Advanced Gastric or Esophagogastric Cancer Using Epirubicin, CISplatin and Capecitabine           


    GIGAVECF

    Palliative Therapy for Metastatic or Locally Advanced Gastric, Esophagogastric Cancer Using Epirubicin, CISplatin and Infusional Fluorouracil        


    GIGAVTR

    Continuation of Palliative Treatment of Metastatic or Inoperable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma using Trastuzumab  


    GIGECC

    Perioperative Treatment of Resectable Adenocarcinoma of the Stomach, Gastroesophageal Junction or Lower 1/3 Esophagus Using Epirubicin, CISplatin and Capecitabine 


    GIGECF

    Perioperative Treatment of Resectable Adenocarcinoma of the Stomach, Gastroesophageal Junction or Lower 1/3 Esophagus Using Epirubicin, CISplatin and Infusional Fluorouracil          


    GIGFOLFIRI

    Palliative Combination Chemotherapy for Metastatic Gastric or Esophageal Adenocarcinoma Using Irinotecan, Fluorouracil and Leucovorin       

    Pancreas, Gall Bladder, Biliary Tract

    GIAVPG

    First-line Palliative Chemotherapy for Advanced Gallbladder Cancer and Cholangiocarcinoma Using Gemcitabine and CISplatin     


    UGIFIRINOX

    Palliative Combination Chemotherapy for Advanced Pancreatic Adenocarcinoma Using Irinotecan, Oxaliplatin, Fluorouracil and Leucovorin       


    GIFUC

    (SEE UNDER ESOPHAGUS, STOMACH SECTION)


    GIPAJGEM

    Adjuvant Chemotherapy for Pancreatic Adenocarcinoma Using Gemcitabine     


    GIPGEM

    Palliative Therapy for Pancreatic Adenocarcinoma, Gallbladder Cancer, and Cholangiocarcinoma Using Gemcitabine        


    UGIPGEMABR

    First Line Treatment of Locally Advanced and Metastatic Pancreatic Cancer with PACLitaxel-Nab (ABRAXANE®) and Gemcitabine           

    Liver

    GIA

    Palliative Therapy for Hepatoma Using DOXOrubicin   


    UGIDEBTACE

    Transarterial Chemoembolization (TACE) of Hepatocellular Carcinoma Using Drug-Eluting Bead (DEB) Loaded with DOXOrubicin     


    UGISORAF

    Therapy for Advanced Hepatocellular Carcinoma Using SORAfenib     


    UGIYTT

    Yttrium-90 for Transarterial Radioembolisation (TARE)      

    Carcinoid & Neuroendocrine Tumours

    GIAVTZCAP

    Palliative Therapy of Metastatic Neuroendocrine Cancer Using Temozolomide and Capecitabine  


    GIENDO2

    Palliative Therapy for Pancreatic Endocrine Tumours Using Streptozocin and DOXOrubicin       


    UGILAN

    Symptomatic Management of Functional Carcinoid and Neuroendocrine Tumors of the GI Tract Using Lanreotide (SOMATULINE AUTOGEL®)

    GINPRRT

    Out-of-Province Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors 


    UGIOCTLAR

    Symptomatic Management of Functional Carcinoid and Neuroendocrine Tumors of the GI Tract Using Octreotide


    GIPE

    Palliative Therapy of Neuroendocrine Tumours Using CISplatin and Etoposide  


    UGIPNEVER

    Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using Everolimus           


    UGIPNSUNI

    Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours Using SUNItinib 

    Others

    GICART

    Combined Modality Therapy for Carcinoma of the Anal Canal Using Mitomycin, Capecitabine and Radiation Therapy

    GICPART

    Combined Modality Therapy for Carcinoma of the Anal Canal Using CISplatin, Capecitabine and Radiation Therapy
     

    GIFUART

    Combined Modality Curative Therapy for Carcinoma of the Anal Canal Using Mitomycin, Fluorouracil and Radiation Therapy

    GIFUPART

    Combined Modality Curative Therapy for Carcinoma of the Anal Canal Using CISplatin, Infusional Fluorouracil and Radiation Therapy

    GIFUC

    (SEE UNDER ESOPHAGUS, STOMACH SECTION)

    GIFUIP

    Chemotherapy of Pseudomyxoma Peritonei Using Intraperitoneal Mitomycin and Fluorouracil


    GIHIPEC

    Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Peritoneal Carcinomatosis from Limited Advanced Colorectal and Appendiceal Carcinomas Using Oxaliplatin and Fluorouracil (5-FU)

    GIPMHIPEC

    Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Peritoneal Mesothelioma Using Doxorubicin, Cisplatin and Paclitaxel
    Terms of use

    The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's Terms of Use.
    Tab Heading
    Tab Heading
    SOURCE: Gastrointestinal ( )
    Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

    Copyright © BC Cancer Agency. All Rights Reserved.

      Copyright © 2016 Provincial Health Services Authority.